Develop and validate a computable phenotype for the identification of Alzheimer's disease patients using electronic health record data

Documenti analoghi

• Alzheimer's and dementia: Diagnosis, assessment, and disease monitoring global, regional, and national burden of Alzheimer's disease and other dementias (ADODs) and their risk factors, 1990–2021: A systematic analysis for the Global Burden of Disease study 2021
  di: Fang Wang, et al.
  Pubblicazione: (2025)
• Criterion and convergent validity of plasma biomarkers in early‐onset Alzheimer's disease: Initial findings from LEADS
  di: Dustin B. Hammers, et al.
  Pubblicazione: (2026)
• Feasibility, validity, and normative data for the remote Uniform Data Set neuropsychological battery at the University of Pennsylvania Alzheimer's Disease Research Center
  di: Katherine Hackett, et al.
  Pubblicazione: (2024)
• Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy‐confirmed cohort from China
  di: Xiang‐Sha Yin, et al.
  Pubblicazione: (2025)
• Factors associated with discordant visual and quantitative amyloid PET results
  di: Jasmin E Guevara, et al.
  Pubblicazione: (2026)